125 related articles for article (PubMed ID: 6460338)
1. Platelet and coagulation function in patients with abnormal cardiac valves treated with sulphinpyrazone.
Ludlam CA; Allan N; Blandford RB; Dowdle R; Bentley NJ; Bloom AL
Thromb Haemost; 1981 Dec; 46(4):743-6. PubMed ID: 6460338
[TBL] [Abstract][Full Text] [Related]
2. Measurement of beta-thromboglobulin and platelet factor 4 to follow up patients with artificial heart valves.
Bellon JL; Castellanos C; Acevedo L; Amiral J
Semin Thromb Hemost; 1993; 19 Suppl 1():178-82. PubMed ID: 8362264
[TBL] [Abstract][Full Text] [Related]
3. Failure of sulphinpyrazone to affect platelet survival in patients with rheumatic heart valvular disease: a double blind study using 75Se-methionine labeled platelets.
Fabris F; Casonato A; Randi ML; Schivazappa L; Schiavinato L; Girolami A
Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(4):594-601. PubMed ID: 6196274
[TBL] [Abstract][Full Text] [Related]
4. Plasma concentration of platelet-specific proteins and fibrinopeptide A in patients with artificial heart valves.
Dudczak R; Niessner H; Thaler E; Lechner K; Kletter K; Frischauf H; Domanig E; Aicher H
Haemostasis; 1981; 10(4):186-94. PubMed ID: 6454613
[TBL] [Abstract][Full Text] [Related]
5. Elevated plasma levels of beta-thromboglobulin and platelet factor 4 in patients with rheumatic disorders and cutaneous vasculitis.
Yamamoto T; Chikugo T; Tanaka Y
Clin Rheumatol; 2002 Nov; 21(6):501-4. PubMed ID: 12447635
[TBL] [Abstract][Full Text] [Related]
6. Detection of enhanced in vivo platelet alpha-granule release in different patient groups--comparison of beta-thromboglobulin, platelet factor 4 and thrombospondin assays.
Lane DA; Ireland H; Wolff S; Ranasinghe E; Dawes J
Thromb Haemost; 1984 Oct; 52(2):183-7. PubMed ID: 6084323
[TBL] [Abstract][Full Text] [Related]
7. Evidence for the need of long-term antithrombotic therapy in patients with porcine heterograft heart valve.
Cella G; Casonato A; Schivazappa L; Girolami A
Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(1):150-5. PubMed ID: 6164610
[TBL] [Abstract][Full Text] [Related]
8. Accumulation of risk factors enhances the prothrombotic state in atrial fibrillation.
Ohara K; Inoue H; Nozawa T; Hirai T; Iwasa A; Okumura K; Lee JD; Shimizu A; Hayano M; Yano K
Int J Cardiol; 2008 Jun; 126(3):316-21. PubMed ID: 17689760
[TBL] [Abstract][Full Text] [Related]
9. [Clinical applications of beta-thromboglobulin and platelet factor 4 radioimmune assays (author's transl)].
Lokiec F; Najean Y
Nouv Presse Med; 1980 Oct; 9(38):2833-4, 2837-8. PubMed ID: 6160454
[TBL] [Abstract][Full Text] [Related]
10. The value of beta TG/PF4 ratio in patients with high platelet count.
Fabris F; Luzzatto G; Girolami A
Thromb Haemost; 1985 Apr; 53(2):288-9. PubMed ID: 2410998
[No Abstract] [Full Text] [Related]
11. Effects of suloctidil on platelet survival time following cardiac valve replacement.
Col-de Beys C; Ferrant A; Moriau M
Thromb Haemost; 1981 Aug; 46(2):550-3. PubMed ID: 6272442
[TBL] [Abstract][Full Text] [Related]
12. Platelet proteins (beta-TG and PF4) in atherosclerosis and related diseases.
Mühlhauser I; Schernthaner G; Silberbauer K; Sinzinger H; Kaliman J
Artery; 1980; 8(1):73-9. PubMed ID: 6158934
[TBL] [Abstract][Full Text] [Related]
13. Serial determinations of PF4 and beta TG: comparisons between multiple venipunctures vs a catheter infusion system.
Strauss W; Cella G; Myers C; Sasahara AA
Thromb Haemost; 1988 Jun; 59(3):491-4. PubMed ID: 2973152
[TBL] [Abstract][Full Text] [Related]
14. Standardization of beta-thromboglobulin and platelet factor 4: a collaborative study to investigate the sources and extent of variation in the measurement of platelet specific proteins.
Curtis AD; Kerry PJ
Thromb Haemost; 1983 Oct; 50(3):686-9. PubMed ID: 6196853
[TBL] [Abstract][Full Text] [Related]
15. Platelet activation in response to phlebotomy. An experimental study of healthy blood donors.
Eriksson KA; Sigvaldason A; Lindholm A; Safai-Kutti S; Kutti J
Acta Med Scand; 1982; 212(3):121-3. PubMed ID: 6183925
[TBL] [Abstract][Full Text] [Related]
16. Elevated platelet factor 4 and beta-thromboglobulin plasma levels in depressed patients with ischemic heart disease.
Laghrissi-Thode F; Wagner WR; Pollock BG; Johnson PC; Finkel MS
Biol Psychiatry; 1997 Aug; 42(4):290-5. PubMed ID: 9270907
[TBL] [Abstract][Full Text] [Related]
17. Effects of recombinant human soluble thrombomodulin (rhs-TM) on a rat model of disseminated intravascular coagulation with decreased levels of plasma antithrombin III.
Aoki Y; Ohishi R; Takei R; Matsuzaki O; Mohri M; Saitoh K; Gomi K; Sugihara T; Kiyota T; Yamamoto S
Thromb Haemost; 1994 Apr; 71(4):452-5. PubMed ID: 8052962
[TBL] [Abstract][Full Text] [Related]
18. Secreted platelet proteins with antiheparin and mitogenic activities in chronic renal failure.
Guzzo J; Niewiarowski S; Musial J; Bastl C; Grossman RA; Rao AK; Berman I; Paul D
J Lab Clin Med; 1980 Jul; 96(1):102-13. PubMed ID: 6446588
[TBL] [Abstract][Full Text] [Related]
19. [Changes in serum beta-thromboglobulin levels during oral contraception, cardiac valve disease and pulmonary embolism (author's transl)].
Conard J; Terrier E; Baillet M; Horellou MH; Jaulmes B; Samama M; Baillet J
Nouv Presse Med; 1981 Apr; 10(16):1327-9. PubMed ID: 6164044
[TBL] [Abstract][Full Text] [Related]
20. In vivo platelet activation following myocardial infarction and acute coronary ischaemia.
Hughes A; Daunt S; Vass G; Wickes J
Thromb Haemost; 1982 Oct; 48(2):133-5. PubMed ID: 6184842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
